Cometriq

Active Ingredient(s): Cabozantinib S Malate
FDA Approved: * November 29, 2012
Pharm Company: * EXELIXIS
Category: Cancer

Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib in its capsule formulation was approved by the U.S. Food and Drug Administration (FDA) under the name Cometriq for treating ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Cabozantinib S-malate
NDC: 11014-0248
Labeler:
Catalent Pharma Solutions, LLC
Cabozantinib S-malate
NDC: 11014-0249
Labeler:
Catalent Pharma Solutions, LLC
Cabozantinib S-malate
NDC: 11014-0250
Labeler:
Catalent Pharma Solutions, LLC
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) / 7 (Cabozantinib 80 mg Oral Capsule [cometriq]) } Pack [cometriq 140 mg Daily Dose Carton]
NDC: 42388-011
Labeler:
Exelixis, Inc.
Cometriq 100 mg Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each
NDC: 42388-012
Labeler:
Exelixis, Inc.
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) } Pack [cometriq 60 mg Daily Dose Carton]
NDC: 42388-013
Labeler:
Exelixis, Inc.
Cometriq 20 mg Oral Capsule
NDC: 42388-014
Labeler:
Exelixis, Inc.

Related Brands

Drugs with the same active ingredients

Popular Topics

cometriq treats lung cancer

Lung cancer treated by cometriq ## Anyone out there living on cometriq? I am stage four lung cancer patient in remission...

2 REPLIES
Cometriq Availability

Hello, I need to be able to get Cometriq for a cousin with Medullary Thyroid Cancer in Argentina. The only problem is th...

2 REPLIES